LegislationAlaska Task Force Backs Psychedelic Therapy Framework Tied to FDA Action
Alaska's psychedelics task force recommends establishing a regulated therapy framework for psilocybin and MDMA, contingent on FDA approval. The year-long study proposes licensing facilitators and testing standards.
Feb 10, 2026
Read
